Document is current
Any future updates will be listed below
-
Authors
McShan, Andrew C.
Devlin, Christine A. https://orcid.org/0000-0002-8541-7432
Morozov, Giora I.
Overall, Sarah A.
Moschidi, Danai
Akella, Neha
Procko, Erik https://orcid.org/0000-0002-0028-490X
Sgourakis, Nikolaos G. https://orcid.org/0000-0003-3655-3902
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (5R01AI143997-04)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (3R35GM125034-05S1, 5R35GM125034-05)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences
- License Information
-
More Information
Article History
Received: 5 December 2020
Accepted: 16 April 2021
First Online: 26 May 2021
Competing interests
: E.P. is a cofounder of Orthogonal Biologics, Inc; the company had no role in this study. N.G.S. is a cofounder of MultiplexThera, Inc., and a named inventor on licensed patents concerning the preparation of peptide-receptive MHC-I molecules; the company had no role in this study. The other authors have no competing interests.
